Under The New Health Care Reform XX Pharmaceutical Companies To Explore The Channel Model Innovation

The pharmaceutical industry of China has been developing very quickly in the lasttwo decades. However, the growth rate of the industry and net profit is declining. Themain problems of the industry include lack of concentration, innovation, experience ininternational marketing and R&D capacity, excess production capacity, high cost, andbackward marketing and sales models. With the new healthcare reform unceasingadvancement, and the essential drug system is fully implemented, the abovecontradiction will become more sharp.The core of sales is Marketing management. Only a sound management foundationcan sustain the growth of sales. The Marketing model is not a single method, but anintegrated management system and marketing philosophy. This thesis aims to findsolutions to improve the domestic pharmaceutical industry’s marketing model andimprove the competitiveness of pharmaceutical companies through a thorough analysisof the Chinese medical industry and the competitive landscape of China’spharmaceutical market, and a study of the pros and cons of various marketing models.